Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    endocrinology

    Primary aldosteronism

    Also known as: Primary hyperaldosteronism, Autonomous aldosterone excess, Aldosterone-mediated endocrine hypertension

    Primary aldosteronism is characterised by autonomous adrenal aldosterone overproduction, resulting in suppressed renin activity and hypertension; normokalaemia does not exclude the diagnosis. Clinical management necessitates biochemical screening and specialist-led subtyping if adrenalectomy is indicated. Primary interventions include mineralocorticoid receptor antagonists or unilateral adrenalectomy. TCM may address secondary symptomatic presentations but cannot delineate adrenal aetiology or substitute for hormone-specific medical therapy. Integrative evidence for hypertension remains limited and inconsistent, with no established efficacy for primary aldosteronism specifically. Current research provides no evidence that acupuncture or herbal medicine confers benefit for this endocrine disorder. Supportive management involves symptom surveillance, ensuring pharmacological adherence, and coordinating the monitoring of blood pressure, serum potassium, and renal function. Spontaneous improvement during pregnancy is often transient and does not indicate resolution, as significant postpartum exacerbation is documented.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Utilise a validated sphygmomanometer for upper-arm measurement and maintain a comprehensive log of blood pressure readings, symptoms, and medication adherence for clinical evaluation.
    • •Consult with the medical team regarding sodium restriction; refrain from using potassium-enriched salt substitutes unless clinically authorised.
    • •Optimise sleep hygiene and engage in moderate physical activity commensurate with current blood pressure control and medical recommendations.
    • •Avoid the consumption of glycyrrhiza (liquorice) in confectionery, teas, or supplements; disclose all herbal products to clinicians and do not cease prescribed pharmacological therapy without medical consultation.

    Cautions & Contraindications

    See sources
    • •Do not use a TCM pattern or response to acupuncture to select an adrenal surgical side or bypass specialist subtyping. The supplied retrospective study concerns specialist interpretation of partially successful adrenal vein sampling, not an alternative-care diagnostic method.[]
    • •Do not discontinue or change antihypertensives during pregnancy because blood pressure improves, or because a case report describes a medication decision. Obstetric and endocrine clinicians must review medication safety and postpartum surveillance individually.[]
    • •Do not present acupuncture or these formulas as proven primary-aldosteronism treatment. The supplied review concerns broader hypertension and reports methodological limitations; it does not establish condition-specific efficacy or formula safety.[]

    When to reassess or seek care again

    See sources

    Review adjunctive care after 2–4 weeks using a seven-day home blood pressure average, dizziness frequency, headache days, sleep quality and adverse effects. Review potassium and renal results at intervals set by the prescriber, especially after medication changes. Escalate promptly for readings repeatedly outside the clinician-agreed range, new weakness, palpitations, syncope or worsening renal/electrolyte results; emergency symptoms require immediate care. Discontinue ineffective adjunctive treatment rather than delaying endocrine management.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Journal of the American Society of Nephrology : JASN · 2026
    2. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2026
    3. International journal of general medicine · 2026
    4. BMC endocrine disorders · 2025

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.